MENU
CV
AS OF
Dec 3 closing price
Price
$6.17
Change
+$0.65 (+11.78%)
Capitalization
289.02M
83 days until earnings call
Intraday BUY SELL Signals
+Compare
CV
Stock ticker: NASDAQ
AS OF
Dec 3 closing price
Price
$6.17
Change
+$0.65 (+11.78%)
Capitalization
289.02M

CV CapsoVision Forecast, Technical & Fundamental Analysis

CapsoVision Inc is a commercial-stage medical technology enterprise, innovates, manufactures, and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal (GI) system... Show more

CV
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for CV with price predictions
Nov 28, 2025

CV's RSI Oscillator peaks and leaves overbought zone

The 10-day RSI Oscillator for CV moved out of overbought territory on November 14, 2025. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 3 instances where the indicator moved out of the overbought zone. In of the 3 cases the stock moved lower in the days that followed. This puts the odds of a move down at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

The Momentum Indicator moved below the 0 level on November 28, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on CV as a result. In of 8 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

CV broke above its upper Bollinger Band on November 11, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for CV just turned positive on November 25, 2025. Looking at past instances where CV's MACD turned positive, the stock continued to rise in of 2 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CV advanced for three days, in of 20 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CV’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (14.144) is normal, around the industry mean (63.271). P/E Ratio (0.000) is within average values for comparable stocks, (37.178). CV's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.671). CV has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.018). P/S Ratio (22.075) is also within normal values, averaging (35.282).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CV’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

View a ticker or compare two or three
CV
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry MedicalNursingServices

Profile
Fundamentals
Details
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BLSFY77.87N/A
N/A
Bluescope Steel, Ltd.
MIELY54.51N/A
N/A
Mitsubishi Electric Corp.
SOCLF0.30N/A
N/A
Pharos Energy PLC
TKCBF5.99N/A
N/A
Tokai Carbon Company Ltd.
ASCN101.00N/A
N/A
Absecon Bancorp